Skip to content
In deliveryUnited KingdomGoodsFramework agreement£29,042,000

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

Awarded to ACCORD-UK LTD, ASTRAZENECA UK LIMITED, Accord-UK Ltd +12 more

NHS ENGLAND(buyer)

Published
Published 9 April 2025
Deadline
Closed 9 June 2025

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

NHS England has awarded a national framework agreement for the supply of transition products Nilotinib and Ticagrelor, commencing 1 September 2025 for 17 months across two regional lots with optional extensions up to a maximum of 24 months. The framework, valued at £44.2 million, was awarded to thirteen suppliers including Accord-UK Ltd, AstraZeneca, Dr Reddy's Laboratories, MSN Laboratories Europe, Novartis Pharmaceuticals, Zentiva Pharma, and Zydus Pharmaceuticals UK.

Contracting authority

  • 13 live opportunities · 817 awarded contracts

    Leeds, United Kingdom

    GB-NHS: X24

  • NHS England

    Buyer

    London, United Kingdom

    GB-PPON: PDPT-3135-BWWY

    Authority website ↗

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£29,042,000
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
9 April 2025
Questions by
2 June 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£44,194,000
Award date
11 June 2025
Contract period
31 August 2025 → 31 January 2027
Winners
  • ACCORD-UK LTD
  • ASTRAZENECA UK LIMITED
  • Accord-UK Ltd
  • AstraZeneca
  • C. S. T. PHARMA LIMITED
  • DR REDDY'S LABORATORIES (UK) LIMITED
  • Dr.Reddy's Laboratories (UK) Limited
  • MSN LABORATORIES EUROPE LIMITED
  • MSN Laboratories Europe Limited
  • NOVARTIS PHARMACEUTICALS UK LIMITED
  • Novartis Pharmaceuticals UK Ltd
  • ZENTIVA PHARMA UK LIMITED
  • ZYDUS PHARMACEUTICALS UK LTD
  • Zentiva Pharma UK Ltd
  • Zydus Pharmaceuticals UK Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    20 August 2025

  2. Contract

    11 July 2025

  3. Contract

    11 July 2025

  4. Tender Update

    7 May 2025

  5. Contract Notice

    7 May 2025

  6. Prior Information Notice

    9 April 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.